February 28, 2009
Looks like Finasteride, sold as Propecia to combat male pattern hair loss, has been clinically proven to help prevent prostate cancer but there are still questions left to be answered about the drug.
This is the first medication that has demonstrated the ability to help prevent prostate disease, experts said. The American Cancer Society notes that more than 186,000 men are diagnosed with prostate cancer each year. Nearly 29,000 die of it. That is why such special attention is being paid to Finasteride.
While previous studies show that Finasteride reduces the overall likelihood of getting prostate cancer by 25%, some doctors are concerned that Finasteride may increase the risk of developing the deadliest types of tumors. However, the most recent analyses have nearly dismissed these worries. According to the American Society of Clinical Oncology and the American Urological Association, the drug’s benefits are a good enough reason for men to discuss Finasteride with their doctors. [Read more]
February 26, 2009
Last week, Dr. Gail Naughton, CEO of Histrogen, Inc. a regenerative medicine company that develops solutions based on the products of newborn fibroblasts grown under embryonic conditions, addressed attendees at the 4th Annual Stem Cell Summit in New York. Dr. Naughton presented preliminary mid-trial results from Histrogen’s first human clinical evaluation of it’s promising breakthrough hair loss product ReGenica™
Histrogen’s clinical trial was primarily designed to assess the safety of its product over a five-month period by using a placebo-controlled, randomized study. Its second objective was to examine ReGenica’s efficiency.
At the 12-week scheduled evaluation point, the company was pleased to announce that they not only found no adverse reactions of ReGenica but also that they could honestly say that they were able to see more hair, thicker hair shafts, and what appeared to be the growth of completely new hair follicles on a siggnificant percentage of the test subjects who were treated with ReGenica.
ReGenica is a liquid formula that is the first naturally stabilized and bioactive formulation of wnt proteins and natural cofactors, which are thought to act in the formation of new hair follicles. The trial is currently ongoing, and Histogen expects to release full results from this first clinical study in the first half of 2009.
February 6, 2009
A South Florida non-surgical hair replacement salon is reporting a record number of calls from South Floridians heading back into the job market and needing a boost of self-esteem. It’s said that consumer spending is at an all time low, and according to The National Association of Insurance Commissioners many Americans are cutting back on everything including medical care, but The Business of Hair keeps growing stronger, giving a whole new meaning to “if you look good, you feel good.”
Jorge Estevez reports for local CBS News4 on this growing trend: